Premium
Ca 2+ ‐NFATc1 signaling is an essential axis of osteoclast differentiation
Author(s) -
NegishiKoga Takako,
Takayanagi Hiroshi
Publication year - 2009
Publication title -
immunological reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.839
H-Index - 223
eISSN - 1600-065X
pISSN - 0105-2896
DOI - 10.1111/j.1600-065x.2009.00821.x
Subject(s) - rankl , microbiology and biotechnology , osteoclast , rank ligand , signal transduction , biology , intracellular , macrophage colony stimulating factor , activator (genetics) , cytokine , nfat , multinucleate , receptor , transcription factor , immunology , macrophage , biochemistry , gene , in vitro
Summary: Osteoclasts are unique, multinucleated giant cells that decalcify and degrade the bone matrix. They originate from hematopoietic cells and their differentiation is dependent on a tumor necrosis factor (TNF) family cytokine, receptor activator of nuclear factor‐κB (NF‐κB) ligand (RANKL), as well as macrophage‐colony stimulating factor (M‐CSF). Recent studies have unveiled the precise molecular mechanism underlying osteoclastogenesis. In particular, the discovery of nuclear factor of activated T cells c1 (NFATc1), the master regulator of osteoclastogenesis, has proven to be a breakthrough in this field. NFATc1 is activated by Ca 2+ signaling induced by the activation of the immunoglobulin‐like receptor signaling associated with immunoreceptor tyrosine‐based activation motif (ITAM)‐harboring adapters. The long‐lasting Ca 2+ oscillation, which is evident during osteoclastogenesis, may ensure the robust induction of NFATc1 through an autoamplification mechanism. Thus, intracellular Ca 2+ is a critical attribute of osteoclastogenic signaling. In addition, osteoclasts are exposed to a very high extracellular Ca 2+ concentration ([Ca 2+ ] o ) in the bone microenvironment and respond to the change in [Ca 2+ ] o by increasing the intracellular Ca 2+ , which regulates diverse cellular functions. Investigation of the molecular mechanisms underlying the regulation of intracellular Ca 2+ dynamics may open up new directions for therapeutic strategies in bone disease.